Choline And Betaine Supplementation Affects Biomarkers In Mice With Gestational Diabetes

juha nam,xinyin jiang
DOI: https://doi.org/10.1096/fasebj.29.1_supplement.754.2
2015-01-01
Abstract:Choline and its oxidized metabolite betaine are involved in one-carbon and energy metabolism. This study examined the effect of choline and betaine supplementation on maternal and fetal outcomes in a model of gestational diabetes mellitus (GDM) in mice. Female C57BL6/J mice were fed either a low-fat (LF) or a high-fat (HF) diet 4 weeks prior to and during pregnancy to induce GDM. HF mice were further divided into 3 subgroups with 25mM choline or 85mM betaine supplemented in drinking water or with plain drinking water as control. Female mice were timed-mated with male mice and placental and fetal samples were collected on embryonic day E12.5. HF mice demonstrated maternal glucose intolerance and higher fetal weight than LF mice indicative of GDM and fetal macrosomia. Choline supplementation tended to alleviate maternal high blood glucose 90 minutes after intraperitoneal glucose injection (P = 0.06) on E11.5 and reduced (P < 0.05) placental and fetal sizes compared to HF control. The betaine supplement group did not yield significant difference in glucose tolerance or fetal size compared to the HF control group. Placental gene transcript abundance of lipid catabolic genes peroxisomal acyl-coenzyme A oxidase 1 and carnitine palmitoyltransferase II was higher (P < 0.05) in both the HF choline and betaine supplement groups than the HF or LF control groups. Taken together, maternal choline or betaine supplementation may improve glucose tolerance, normalize fetal size and reduce placental lipid accumulation of HF diet-induced GDM mice.
What problem does this paper attempt to address?